What is Bioelectronics Corporation (BIEL)?

Bioelectronics Corporation (BIEL) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of BIEL?

The current price of BIEL is $0.00. Prices are updated in real time on Stocks360.

What is BIEL's price-to-earnings (PE) ratio?

BIEL's trailing twelve-month PE ratio is -9.28, based on current price and earnings per share data available on Stocks360.

What is BIEL's market capitalization?

BIEL's market capitalization is $4,941,020.00, placing it in the small-cap tier.

Bioelectronics Corporation (BIEL)

Stock analysis · OTC · Healthcare · Medical - Specialties

$0.00

Market Cap

$4.94M

PE (TTM)

-9.28

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.02

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

1.58M

Bioelectronics Corporation (BIEL) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $4.94M. Trailing PE -9.28. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.00 2026-10-30 · $0.00 (-40.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bioelectronics Corporation

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-9.28×
P/S (TTM)	9.68×
P/B	-0.28×
P/FCF (TTM)	-32.63×
EV / EBITDA	261.20×
EV / Sales	41.57×
Earnings Yield	-10.78%
Free Cash Flow Yield	-3.06%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$21.23M
Revenue (TTM)	$510.62K
Net Income (TTM)	-$532.49K
Free Cash Flow (TTM)	$462.34K
Net Debt	$16.29M
Working Capital	-$3.57M
Gross Margin	84.87%
Operating Margin	15.91%
Net Margin	-104.28%
Return on Equity	3.01%
Return on Invested Capital	-4.92%